Belpointe Asset Management LLC Exelixis, Inc. Transaction History
Belpointe Asset Management LLC
- $2.14 Billion
- Q2 2025
A detailed history of Belpointe Asset Management LLC transactions in Exelixis, Inc. stock. As of the latest transaction made, Belpointe Asset Management LLC holds 15,984 shares of EXEL stock, worth $552,087. This represents 0.03% of its overall portfolio holdings.
Number of Shares
15,984
Previous 15,487
3.21%
Holding current value
$552,087
Previous $571,000
23.29%
% of portfolio
0.03%
Previous 0.03%
Shares
4 transactions
Others Institutions Holding EXEL
# of Institutions
687Shares Held
259MCall Options Held
1.41MPut Options Held
1.55M-
Black Rock Inc. New York, NY33.5MShares$1.16 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA27.5MShares$949 Million0.02% of portfolio
-
Farallon Capital Management LLC San Francisco, CA16MShares$554 Million3.18% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny15.8MShares$546 Million0.99% of portfolio
-
State Street Corp Boston, MA11.4MShares$393 Million0.02% of portfolio
About EXELIXIS, INC.
- Ticker EXEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 321,832,000
- Market Cap $11.1B
- Description
- Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...